Mitigating yellow-fever-vaccine-associated viscerotropic disease in older travellers

Abstract

Following two recent fatal yellow fever vaccine associated adverse reactions, a review of the safety of the yellow fever vaccine was undertaken in the UK. While the review found the administration of yellow fever vaccine remained favourable for most travellers, when used as indicated, a number of changes to clinical practice were mandated.